Concert Pharma Stock Price (NASDAQ:CNCE)

Add to My Stocks
$17.39 $0.01 (0.06%) CNCE stock closing price Mar 27, 2017 (Closing)
Concert Pharma
27 MAR 2017
amigobulls logo
CNCE hand_up
CNCE vs S&P 500
Closing Price: Mar 27, 2017
$17.39 ( -0.03%)
S&P 500
2341.6 ( -0.1%)
52 Week Price Range
1 Year Return: 36.22%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Concert Pharma Snapshot Video

5 5 2

CNCE Stock Details

Prev Close* : $17.40
Market Cap:
Day Low: $16.74
52 Week Low: $7.11
Open: $17.04
Volume: 385345
Day High: $17.67
52 Week High: $19.11

Latest Stock Market News

Latest Articles

Concert Pharma News - From Partners

CNCE Stockcharts

View CNCE PE ratio, PS ratio stocks charts and compare with peers.
CNCE Chart
Note: Compare Concert Pharma stock price history with the index and industry peers.

Concert Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Concert Pharma Financial Ratios

Receivables Turnover

CNCE Industry Peers

Company Price Change (%)
Avadel Pharma (AVDL)9.180.03 (0.33%)
Karyopharm Therapeutics (KPTI)10.830.35 (3.34%)
Celgene (CELG)124.861.48 (1.2%)
Jazz Pharma (JAZZ)146.983.84 (2.68%)
Vertex Pharma (VRTX)90.80.82 (0.91%)
Auspex Pharma (ASPX)100.960 (0%)
Proteostasis (PTI)11.431.04 (10.01%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Catalyst Pharma (CPRX)2.010.31 (18.24%)
Aralez Pharma (ARLZ)2.420.23 (10.5%)
Rigel Pharma (RIGL)3.430.3 (9.58%)
Flexion Therapeutics (FLXN)29.261.99 (7.3%)
Cempra (CEMP)4.350.25 (6.1%)
Endo International (ENDP)10.50.53 (5.32%)
Corcept Therapeutics (CORT)10.650.53 (5.24%)
Top gainers from Medical-Drugs industry
* As of Mar 28, 2017
CompanyPriceChange (%)
Redhill Biopharma (RDHL)10.230.24 (2.29%)
Tesaro Inc (TSRO)156.733.27 (2.04%)
Esperion Therapeutics (ESPR)38.270.67 (1.72%)
Ignyta (RXDX)9.150.1 (1.08%)
AcelRx Pharma (ACRX)3.050.03 (0.98%)
Xencor (XNCR)24.30.23 (0.94%)
La Jolla Pharma (LJPC)34.630.29 (0.83%)
Top losers from Medical-Drugs industry
* As of Mar 28, 2017

Concert Pharmaceuticals Inc Stock News - Partner Headlines

Concert Pharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues66.72M8.57M25.4M12.84M19.46M
Net Income24.17M-31.69M-6.05M-20.44M-11.32M
Total Operating Expense41.93M39.17M29.81M31.45M30.8M
view Concert Pharmaceuticals Inc income statement
balance sheet20152014201320122011
Total Assets146.93M84.45M39.77M33.12M-
Total Liabilities16.29M29.62M39.63M27.96M-
Shareholders Equity130.63M54.82M0.14M5.16M-
view Concert Pharmaceuticals Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-5.39M-1.52M16.79M-8.58M-9.54M
Net Cash From (Used By) Operating Activities23.06M-29.76M13.01M-26.42M-18.08M
Increase (Decrease) In Prop Plant And Equipment-0.86M-0.8M-0.36M-0.46M-0.29M
view Concert Pharmaceuticals Inc cashflow statement

Concert Pharma Stock Message Board

Concert Pharma stock lost -0.03 %, and the last close price as of 27 Mar, 2017 is 17.39 for CNCE stock. Concert Pharma market capitalization is 388.41M and it represents the total market value of CNCE stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Concert Pharma stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Concert Pharma is worth a lot, it will most likely be reflected in an inflated Concert Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 385345 shares were traded with a closing stock price of 17.39 as of 27 Mar, 2017, as can be seen from Concert Pharma stock quote. One can view Concert Pharma stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Concert Pharma does not pay dividends. One can observe stock price trends and check for volatility by checking Concert Pharma stock price history.